Regulators Question Safety of Growth Hormone After Study Shows Increased Risk of Death Among Adults Treated With Hormone as Children

As reported on MedPage Today, in early December, the European Medicines Agency (EMA) (the European Union's equivalent of the FDA) announced it will investigate the safety of growth hormone (known generically as somatropin) used to treat growth hormone deficiency and short stature in children.  The review is based on data from a long-term study of… Learn More »